Stocks and Investing Stocks and Investing
Thu, October 28, 2021

Tiago Fauth Maintained (BMRN) at Buy with Decreased Target to $100 on, Oct 28th, 2021


Published on 2024-10-27 18:22:27 - WOPRAI, Tiago Fauth
  Print publication without navigation


Tiago Fauth of Credit Suisse, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $102 to $100 on, Oct 28th, 2021.

Tiago has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 1 agrees with Tiago's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $88 on, Thursday, July 29th, 2021


This is the rating of the analyst that currently disagrees with Tiago


  • Paul Matteis of "Stifel" Upgraded from Hold to Strong Buy and Increased Target to $96 on, Thursday, September 9th, 2021
Contributing Sources